Tang Qing-Feng, Sun Jian, Yu Hui, Shi Xiao-Jing, Lv Rong, Wei Hong-Chang, Yin Pei-Hao
Central Laboratory and Department of Clinical Laboratory, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200062, China; Basic Medical College, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Central Laboratory and Department of Clinical Laboratory, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200062, China.
Evid Based Complement Alternat Med. 2016;2016:8203789. doi: 10.1155/2016/8203789. Epub 2016 Oct 30.
Despite the status of cisplatin (DDP) as a classical chemotherapeutic agent in the treatment of cancer, the development of multidrug resistance often leads to a failure of DDP therapy. Here we found that phosphorylated cofilin-1 (p-cofilin-1) was overexpressed in the DDP-resistant human gastric cancer cell lines SGC7901/DDP and BGC823/DDP, relative to the respective parent cell lines (SGC7901 and BGC823), and that DDP induced the dephosphorylation of p-cofilin-1 in both parent lines but not in the DDP-resistant lines. However, we noted that the traditional Chinese medicine formula Zuo Jin Wan (ZJW) could induce the dephosphorylation of p-cofilin-1 and promote cofilin-1 translocation from the cytoplasm into the mitochondria in both SGC7901/DDP and BGC823/DDP cells. This mitochondrial translocation of cofilin-1 was found to induce the conversion of filamentous actin to globular-actin, activate mitochondrial damage and calcium overloading, and induce the mitochondrial apoptosis pathway. We further observed that these effects of ZJW on DDP-resistant human gastric cancer cell lines could be reversed via transfection with cofilin-1-specific siRNA, or treatment with a PP1 and PP2A inhibitor. These results suggest that ZJW is an effective drug therapy for patients with DDP-resistant gastric cancer.
尽管顺铂(DDP)作为治疗癌症的经典化疗药物,但多药耐药性的发展常常导致DDP治疗失败。在此,我们发现相对于各自的亲本细胞系(SGC7901和BGC823),磷酸化丝切蛋白-1(p-丝切蛋白-1)在耐DDP的人胃癌细胞系SGC7901/DDP和BGC823/DDP中过表达,并且DDP在两个亲本细胞系中均可诱导p-丝切蛋白-1的去磷酸化,但在耐DDP的细胞系中则不然。然而,我们注意到中药方剂左金丸(ZJW)可诱导SGC7901/DDP和BGC823/DDP细胞中p-丝切蛋白-1的去磷酸化,并促进丝切蛋白-1从细胞质向线粒体的转位。发现丝切蛋白-1的这种线粒体转位可诱导丝状肌动蛋白向球状肌动蛋白的转化,激活线粒体损伤和钙超载,并诱导线粒体凋亡途径。我们进一步观察到,ZJW对耐DDP的人胃癌细胞系的这些作用可通过用丝切蛋白-1特异性siRNA转染或用PP1和PP2A抑制剂处理来逆转。这些结果表明,ZJW是治疗耐DDP胃癌患者的有效药物疗法。